The global Medical Device Testing Services Market size is expected to reach USD 18.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. Increasing complexity in product design and stringent government regulations are driving the market.
A significant rise in preclinical spending is a recent
trend among pharmaceutical and medical device companies, which is expected to
significantly contribute to market growth. As per a survey carried out by the
International Federation of Pharmaceutical Manufacturers and Associations in
2017, around USD 149.8 billion is spent on preclinical trials every year.
With modern medical equipment offering a host of
complex functions, the need for appropriate tests to check the compliance of
the device with regulatory requirements is becoming vital. In order to meet the
requirement of enhanced accuracy, ease of use, and durability, medical devices
need to undergo extensive tests. This is expected to deliver a competitive
advantage to manufacturers.
The COVID-19 pandemic has created an unprecedented
demand for medical device testing services in 2020. This is largely due to the
increasing demand for COVID-10 related products such as masks, PPE, and
respiratory equipment. Besides, countries such as Mexico, Spain,
and France have published pertinent specifications and standards,
namely the UNE 0064-1, UNE 0064-2, AFNOR-SPEC-S76 and UNE 0065 which must
be met until a mask can be sold.
Related Press Release@ Medical Device Testing Services Market Report
Medical Device Testing Services
Market Report Highlights
- The microbiology and sterility testing segment dominated the market
in 2020 and accounted for the largest revenue share of 34.1%. The segment
is likely to remain dominant over the forecast period
- Producing safe and effective products is a core goal of medical
equipment manufacturers and sterility assurance is a major component for
achieving it
- The preclinical phase segment dominated the market in 2020 and
accounted for 65.7% of the revenue share as this stage is mostly focused
on assessing the safety and biocompatibility of medical devices
- Raw materials, packaging, and design all have an impact on a
device's safety and compatibility, and preclinical testing of all of these
factors is an important step in determining a device's market potential
- Asia Pacific dominated the market and accounted for 41.8% of the
revenue share in 2020. This is due to the rising demand for medical
devices in developing nations such as India and China
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, the company offers market intelligence studies ensuring relevant and
fact-based research across a range of industries including technology,
chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment